Big Board

Keyword
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Case 30-2020: A 54-Year-Old Man with Sudden Cardiac Arrest | NEJM
2 Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes | NEJM
3 Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
4 Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment
5 Tribal Truce — How Can We Bridge the Partisan Divide and Conquer Covid?
6 Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
7 The Path Forward — An Antiracist Approach to Academic Medicine
8 New Order, New Hope | NEJM
9 Colchicine in Patients with Chronic Coronary Disease | NEJM
10 SARS-CoV-2 Infection of Airway Cells | NEJM
11 Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
12 Antisense Inhibition of Prekallikrein to Control Hereditary Angioedema
13 Facial Masking for Covid-19 — Potential for “Variolation” as We Await a Vaccine
14 Loss of Anti–SARS-CoV-2 Antibodies in Mild Covid-19 | NEJM
15 The Power of Antibody-Based Surveillance | NEJM
16 Covid-19 Molecular Diagnostic Testing — Lessons Learned | NEJM
17 Family Meetings on Behalf of Patients with Serious Illness
18 Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma
19 Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer | NEJM
20 Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing | NEJM
21 Am I Racist? | NEJM
22 Evaluating and Deploying Covid-19 Vaccines — The Importance of Transparency, Scientific Integrity, and Public Trust
23 Dapagliflozin in Patients with Chronic Kidney Disease | NEJM
24 Community Health Workers and Covid-19 — Addressing Social Determinants of Health in Times of Crisis and Beyond
25 A Pandemic within a Pandemic — Intimate Partner Violence during Covid-19
26 Bridging the Gap at Warp Speed — Delivering Options for Preventing and Treating Covid-19
27 Ebola Response Priorities in the Time of Covid-19 | NEJM
28 “When Will We Have a Vaccine?” — Understanding Questions and Answers about Covid-19 Vaccination
29 Weight Loss in Underserved Patients — A Cluster-Randomized Trial
30 Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
31 “A Menace to the Public Health” — Contact Tracing and the Limits of Persuasion
32 Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer
33 Health Equity — Are We Finally on the Edge of a New Frontier? | NEJM
34 When Actions Speak Louder Than Words — Racism and Sickle Cell Disease
35 NEJM — European Society of Cardiology 2020 — ESC
36 Savara Announces New England Journal of Medicine (NEJM) Publication of IMPALA Study Results
37 Up Is Down — Pharmaceutical Industry Caution vs. Federal Acceleration of Covid-19 Vaccine Approval
38 New England Journal of Medicine publishes positive final results from Phase 1/2a study of BIVV001 in people with severe hemophilia A
39 Universal Masking in the Covid-19 Era | NEJM
40 Novavax Announces Publication of Phase 1 Data for COVID-19 Vaccine Candidate in The New England Journal of Medicine
41 Amylyx Pharmaceuticals Announces New England Journal of Medicine Publication of Pivotal AMX0035 Data Demonstrating Statistically Significant Benefit in People with ALS
42 Covid-19 — Navigating the Uncharted | NEJM
43 Plans and Pandemics | NEJM
44 In Pursuit of PPE | NEJM
45 Medical Journals and the 2019-nCoV Outbreak | NEJM
46 Study Published in The New England Journal of Medicine Demonstrates Patients Experience Fewer Disruptions to Dialysis Therapy When Treated with Medtronic Drug-Coated Balloon
47 Stolen Breaths | NEJM
48 Research in the Context of a Pandemic | NEJM
49 Staying Ahead of the Wave | NEJM
50 Expression of Concern: Mehra MR et al. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.
51 Making the Call | NEJM
52 Waiting for Something Positive | NEJM
53 The Urgency of Care during the Covid-19 Pandemic — Learning as We Go
54 Covid-19 — A Reminder to Reason | NEJM
55 Ten Weeks to Crush the Curve | NEJM
56 The RECOVERY Platform | NEJM
57 Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms
58 Opening Up New Supply Chains | NEJM
59 Of Heroes and Cowards | NEJM
60 Where Do the Children Play? | NEJM
61 Ensuring and Sustaining a Pandemic Workforce | NEJM
62 New England Journal of Medicine publishes final overall survival data for darolutamide showing treatment significantly extends life in men with non-metastatic prostate cancer
63 The Ritual of the Table | NEJM
64 Severe Covid-19 | NEJM
65 Waiting | NEJM
66 Neuropathological Features of Covid-19 | NEJM
67 How Medical Education Is Missing the Bull's-eye | NEJM
68 Efficacy of Selpercatinib in RET-Altered Thyroid Cancers | NEJM
69 Age, Complexity, and Crisis — A Prescription for Progress in Pandemic
70 Contact Tracing for Native Americans in Rural Arizona | NEJM
71 Clinical Characteristics of Covid-19 in China | NEJM
72 Pandemic and Persona | NEJM
73 Preventing a Parallel Pandemic — A National Strategy to Protect Clinicians' Well-Being
74 Covid-19 — The Search for Effective Therapy | NEJM
75 The New Stability | NEJM
76 Remdesivir for the Treatment of Covid-19 — Preliminary Report
77 Diversity, Equity, and Inclusion That Matter | NEJM
78 Compassionate Use of Remdesivir in Covid-19 | NEJM
79 Once Upon a Time…the Hero Sheltered in Place | NEJM
80 New England Journal of Medicine Publishes Final Data for NUBEQA® (darolutamide) Plus Androgen Deprivation Therapy Showing a Statistically Significant Improvement in Overall Survival in Men with Non-Metastatic Castration-Resistant Prostate Cancer
81 The Expert When the Only | NEJM
82 Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.
83 From a Sprint to a Marathon in Hong Kong | NEJM
84 Reopening Primary Schools during the Pandemic | NEJM
85 Inequity in Crisis Standards of Care | NEJM
86 BAVENCIO Pivotal Phase III JAVELIN Bladder 100 Results Published in The New England Journal of Medicine
87 Telephone | NEJM
88 Why I Stay — The Other Side of Underrepresentation in Academia
89 Causal Genetic Variants in Stillbirth | NEJM
90 Multisystem Inflammatory Syndrome in Children in New York State
91 Challenges of “Return to Work” in an Ongoing Pandemic | NEJM
92 Successful Elimination of Covid-19 Transmission in New Zealand
93 Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young
94 Remdesivir — An Important First Step | NEJM
95 The Untold Toll — The Pandemic's Effects on Patients without Covid-19
96 Personal Protective Equipment and Covid-19 | NEJM
97 Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2
98 Early Rhythm-Control Therapy in Patients with Atrial Fibrillation | NEJM
99 Dr. Richard Feldman: Steps to affordable health care for all
100 Virtually Perfect? Telemedicine for Covid-19 | NEJM